Miami, FL – CCM Clinical Research Group categorically denies the unsubstantiated allegations published in a recent Science.org article regarding purported data irregularities in certain Alzheimer’s disease clinical trials.
The article references a lawsuit filed by T3D Therapeutics against multiple parties, including CCM Clinical Research Group, related to a clinical research trial of an experimental compound. CCM has reviewed these allegations in detail and firmly asserts that they are without merit. There is no credible evidence to support the claims of data falsification, improper participant enrollment, or any other misconduct at our site.
CCM Clinical Research Group has a long-standing commitment to the highest standards of ethical conduct, scientific integrity, and patient safety in all its clinical research activities. We operate in full compliance with FDA regulations, Good Clinical Practice (GCP) guidelines, and all applicable protocols. Our dedicated team of professionals undergoes rigorous training and oversight to ensure the accuracy and reliability of all trial data and results.
We have cooperated fully with any inquiries or inspections related to our work and will continue to do so. CCM stands ready to address any legitimate concerns through appropriate regulatory and legal channels.
These baseless accusations do a disservice to the critical work of advancing treatments for Alzheimer’s disease and other conditions, as well as to the patients and families who rely on trustworthy clinical research.
CCM Clinical Research Group remains focused on our mission: delivering high-quality, reliable clinical trial services to support the development of innovative therapies that can improve lives.
For media inquiries, please contact:
Brian D. Gottlieb, Esq. – 754-701-3542
bgottlieb@gwfloridalaw.com
Counsel for CCM Clinical Research Group
Website: ccmclinicalresearch.com
3659 South Miami Ave, Suite 5003 Miami, Fl 33133 Tel: (305) 285-0705 Fax: (305) 285-0707
CASE INFORMATION
Florida Circuit Court, Miami-Dade County
T3d Therapeutics, Inc. v. Clinilabs, LLC
Case No. 2025-014285-CA-01
CCM Clinical Research Group is a for-profit, privately owned company located on the Mercy Hospital medical campus, in the medical office building. We are owned and operated by a group of clinicians with over 70 years of combined experience in the medical field. We put our resources together in 2014, combining our knowledge and years of experience, in order to conduct the highest quality research trials.
CCM Clinical Research Group
3659 South Miami Ave, Suite 5003 Miami, Fl 33133
754-701-3542
bgottlieb@gwfloridalaw.com
http://ccmclinicalresearch.com/
Press Contact : Brian Gottlieb
Distributed by Law Firm Newswire
